Abstract:Influenza A virus (IAV) infection causes acute respiratory disease with potential severe and deadly complications. Viral pathogenesis is not only due to the direct cytopathic effect of viral infections but also to the exacerbated host inflammatory responses. Influenza viral infection can activate various host signaling pathways that function to activate or inhibit viral replication. Our previous studies have shown that a receptor tyrosine kinase TrkA plays an important role in the replication of influenza viruses in vitro , but its biological roles and functional mechanisms in influenza viral infection have not been characterized. Here we show that IAV infection strongly activates TrkA in vitro and in vivo . Using a chemical-genetic approach to specifically control TrkA kinase activity through a small molecule compound 1NMPP1 in a TrkA knock-in (TrkA KI) mouse model, we show that 1NMPP1-mediated TrkA inhibition completely protected mice from a lethal IAV infection by significantly reducing viral loads and lung inflammation. Using primary lung cells isolated from the TrkA KI mice, we show that specific TrkA inhibition reduced IAV viral RNA synthesis in airway epithelial cells (AECs) but not in alveolar macrophages (AMs). Transcriptomic analysis confirmed the cell-type-specific role of TrkA in viral RNA synthesis, and identified distinct gene expression patterns under the TrkA regulation in IAV-infected AECs and AMs. Among the TrkA-activated targets are various proinflammatory cytokines and chemokines such as IL6, IL-1β, IFNs, CCL-5, and CXCL9, supporting the role of TrkA in mediating lung inflammation. Indeed, while TrkA inhibitor 1NMPP1 administered after the peak of IAV replication had no effect on viral load, it was able to decrease lung inflammation and provided partial protection in mice. Taken together, our results have demonstrated for the first time an important biological role of TrkA signaling in IAV infection, identified its cell-type-specific contribution to viral replication, and revealed its functional mechanism in virus-induced lung inflammation. This study suggests TrkA as a novel host target for therapeutic development against influenza viral disease. Despite the annual vaccination program and several antiviral options, influenza viruses continue to cause annual epidemics, occasional zoonotic infections and pandemics in humans. Effective antiviral therapeutics are needed to combat severe influenza respiratory disease, which is caused by both the direct viral cytopathic effect and the exacerbated host inflammatory responses. In this study, we show that a host receptor tyrosine kinase TrkA signaling is functionally important for promoting both influenza viral replication and virus-induced lung inflammation. Using a unique mouse model and its derived primary lung cells, in which the TrkA kinase activity can be specifically controlled by a small compound inhibitor, we demonstrated the important role of TrkA in the influenza A viral infection in animals and revealed its cell-type-specific functional mechanisms in promoting viral replication and lung inflammation. Our study suggests TrkA as a potential novel host target for developing effective therapeutics against influenza viral diseases.

The c-Jun N-terminal kinase (JNK) is involved in H5N1 influenza A virus RNA and protein synthesis

Regulation of influenza A virus mRNA splicing by CLK1

Critical Role of Micrornas in Host and Influenza A (H1N1) Virus Interactions.

The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication

HIF-1α promotes virus replication and cytokine storm in H1N1 virus-induced severe pneumonia through cellular metabolic reprogramming

Three Amino Acid Substitutions in the NS1 Protein Change the Virus Replication of H5N1 Influenza Virus in Human Cells

Axin1: A Novel Scaffold Protein Joins the Antiviral Network of Interferon

In Vitro and In Vivo Antiviral Activity of Gingerenone A on Influenza A Virus Is Mediated by Targeting Janus Kinase 2

Nonmuscle Myosin IIA Promotes the Internalization of Influenza A Virus and Regulates Viral Polymerase Activity Through Interacting with Nucleoprotein in Human Pulmonary Cells.

The H5N1-NS1 protein affects the host cell cycle and apoptosis through interaction with the host lncRNA PIK3CD-AS2

Lnc-RPS6P3 Inhibits Influenza A Virus Replication and Attenuates the Inhibitory Effect of NS1 on Innate Immune Response

The Identification and Function of Linc01615 on Influenza Virus Infection and Antiviral Response

KRT10 plays an important role in the release of viral genome from endosomes during H9N2 subtype AIV replication in HeLa cells

MicroRNA-200c-targeted contactin 1 facilitates the replication of influenza A virus by accelerating the degradation of MAVS

Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9

Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation

JNK and p38 mitogen-activated protein kinase pathways contribute to porcine epidemic diarrhea virus infection

The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling

The Nucleoprotein of H7N9 Influenza Virus Positively Regulates TRAF3-Mediated Innate Signaling and Attenuates Viral Virulence in Mice

Inhibition of Human Natural Killer Cell Activity by Influenza Virions and Hemagglutinin

Virus subtype-specific suppression of MAVS aggregation and activation by PB1-F2 protein of influenza A (H7N9) virus